Time | Title | Presenter | Affiliation |
---|---|---|---|
08:30-08:50 | Registration | ||
08:50-09:00 | Welcome address | 곽호신 | KSNO 회장 |
09:00-10:00 | Session I: Free paper I | ||
좌장: | 조재호 황정현 |
연세대 방사선종양학과 경북대 신경외과 |
|
09:00-09:10 | A nationwide, population-based epidemiology study of primary central nervous system tumors in Korea, 2007-2016: A comparison with United States data | 강호 | 서울대 신경외과 |
09:10-09:20 | MR imaging parameters for noninvasive prediction of EGFR amplification in IDH-wildtype lower-grade gliomas: A multicenter study | 박예원 | 연세대 영상의학과 |
09:20-09:30 | Autologous adoptive immune-cell therapy elicited a durable response with enhanced immune reaction signatures in patients with recurrent glioblastoma: An open label, phase I/IIa trial | 임재준 | 차의과학대 신경외과 |
09:30-09:40 | Inhibition of MUC1 exerts cell-cycle arrest and telomerase suppression in glioblastoma cells | 서영범 | 영남대 신경외과 |
09:40-09:50 | Therapeutic efficacy of GC1118, a novel Anti-EGFR antibody, against glioblastoma with high EGFR amplification in patient-derived xenografts EGFR | 최승원 | 성균관대 신경외과 |
09:50-10:00 | Apparent diffusion coefficient as a prognostic factor in clival chordoma | 오형철 | 연세대 신경외과 |
10:00-10:30 | Session II: Award Lecture | ||
좌장: | 곽호신 | 국립암센터 신경외과 | |
10:00-10:10 | KSNO Scientific Award I - Upfront chemotherapy followed by response adaptive radiotherapy for intracranial germinoma: Prospective multicenter cohort study | 이동수 | 가톨릭대 방사선종양학과 |
10:10-10:20 | KSNO Scientific Award II - Optimization of Intracranial Germinoma Treatment: Radiotherapy Alone With Reduced Volume and Dose | 변화경 | 연세대 방사선종양학과 |
10:20-10:30 | KSNO Scientific Award (BTRT) - Re-Irradiation and Its Contribution to Good Prognosis in Recurrent Glioblastoma Patients | 김미선 | 차의과학대 방사선종양학과 |
10:30-10:45 | Coffee break | ||
10:45-11:15 | Session III: Special Lecture I | ||
좌장: | 홍용길 | 가톨릭대 신경외과 | |
Genome editing using CRISPR, base editors, and prime editors | 김형범 | 연세대 약리학교실 | |
11:15-12:15 | Session IV: Symposium I (CNS metastasis) | ||
좌장: | 윤환중 | 충남대 혈액종양내과 | |
11:15-11:35 | Biology and molecular underpinnings of brain metastases | 이세훈 | 성균관대 종양내과 |
11:35-11:55 | Evolving radiotherapy in brain metastases | 윤홍인 | 연세대 방사선종양학과 |
11:55-12:15 | Developments in targeted therapies and immunotherapies | 강은주 | 고려대 종양내과 |
12:15-13:15 | Lunch | ||
13:15-13:45 | Session V: Symposium II (cIMPACT-NOW update) | ||
좌장: | 임도훈 | 성균관대 방사선종양학과 | |
cIMPACT-NOW update_Introduction, practical summary, and future perspectives | 박성혜 | 서울대 병리과 | |
13:45-14:45 | Session VI: Symposium III (Recent update in clinical neuro-oncology) | ||
좌장: | 정동섭 | 가톨릭대 신경외과 | |
13:45-14:05 | Tumor treating fields; basic concept and clinical application | 윤명근 | 고려대 바이오의공학부 |
14:05-14:25 | Advanced neuroimaging of brain tumors | 박지은 | 울산대 영상의학과 |
14:25-14:45 | Perspectives of digital biopsy in brain tumor | 김의현 | 연세대 신경외과 |
14:45-15:00 | Coffee break | ||
15:00-16:00 | Session VII: Free paper II | ||
좌장: | 김세혁 김영준 |
아주대 신경외과 성균관대 신경외과 |
|
15:00-15:10 | Combinatorial therapeutic effect of inhibitors of aldehyde dehydrogenase and mitochondrial complex I, and the chemotherapeutic drug, temozolomide against glioblastoma tumorspheres | 박현호 | 연세대 신경외과 |
15:10-15:20 | Comparative analysis of upfront whole-brain radiation therapy with 23.4 Gy to omission of radiation therapy after high-dose methotrexate for primary central nervous system lymphoma | 김나리 | 성균관대 방사선종양학과 |
15:20-15:30 | A glioneuronal tumor with CLIP2-MET fusion | Tamrin Chowdhury | 서울대 신경외과 |
15:30-15:40 | Genomic signatures underlie the distinct failure patterns of malignant gliomas | 최승원 | 성균관대 신경외과 |
15:40-15:50 | Association between temporal muscle thickness and clinical outcomes in patients with newly diagnosed glioblastoma | 안스데반 | 가톨릭대 신경외과 |
15:50-16:00 | Retrospective analysis of clinical course and risk factors of leptomeningeal metastasis in glioma | 양제열 | 국립암센터 뇌종양척수클리닉 |
16:00-16:30 | Session VIII: Special Lecture II | ||
좌장: | 김세훈 | 연세대 병리과 | |
Molecular mechanisms and novel diagnostic approaches in glioma | Guido Reifenberger | Heinrich Heine University Düsseldorf, Germany | |
16:30-16:50 | Session IX: KSNO Guidelines | ||
좌장: | 박철기 | 서울대 신경외과 | |
16:30-16:40 | The Korean Society for Neuro-Oncology (KSNO) Guidelines for Adult Diffuse midline glioma | 윤홍인 | 연세대 방사선종양학과 |
16:40-16:50 | The Korean Society for Neuro-Oncology (KSNO) Guideline for Antiepileptic drug usage of Brain Tumor | 문장섭 | 서울대 신경과 |
16:50-17:00 | General Assembly & Closing Remark |